Back to Search
PRAKASH CHINNAIYAN, M.D.
M.D.
Radiation Oncology Physician
NPI: 1467402172IndividualAccepts Medicare
Specialties, Licenses & Credentials
Therapeutic Radiology Physician
Radiology — Therapeutic Radiology
Code: 2085R0203X
47459(WI)
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
4301106591(MI)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE
Class of 2000
Research & Publications (14)
Simulation of intrafraction motion and overall geometrical accuracy of a frameless intracranial radiosurgery process.
PMID 19020489·J Appl Clin Med Phys·2008
8-other
The prognostic value of nestin expression in newly diagnosed glioblastoma: report from the Radiation Therapy Oncology Group.
PMID 18817556·Radiat Oncol·2008
8-other
Postradiation sensitization of the histone deacetylase inhibitor valproic acid.
PMID 18765532·Clin Cancer Res·2008
8-other
Radiation-induced gene translation profiles reveal tumor type and cancer-specific components.
PMID 18483266·Cancer Res·2008
8-other
Clinical advancement of EGFR inhibitors in cancer therapy.
PMID 16780222·Methods Mol Biol·2006
6-review
Radiation and new molecular agents, part II: targeting HDAC, HSP90, IGF-1R, PI3K, and Ras.
PMID 16378908·Semin Radiat Oncol·2006
6-review
Enhancing the antitumor activity of ErbB blockade with histone deacetylase (HDAC) inhibition.
PMID 16152586·Int J Cancer·2006
8-other
Modulation of radiation response by histone deacetylase inhibition.
PMID 15850925·Int J Radiat Oncol Biol Phys·2005
8-other
Modern external beam radiation therapy for refractory dissecting cellulitis of the scalp.
PMID 15840113·Br J Dermatol·2005
8-other
Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).
PMID 15833866·Cancer Res·2005
7-preclinical
The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy.
PMID 15708257·Int J Radiat Oncol Biol Phys·2005
3-trial
Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.
PMID 15289342·Cancer Res·2004
4-observational
The impact of mid-treatment MRI on defining boost volumes in the radiation treatment of glioblastoma multiforme.
PMID 15161323·Technol Cancer Res Treat·2004
4-observational
3D-ultrasound guided radiation therapy in the post-prostatectomy setting.
PMID 14529311·Technol Cancer Res Treat·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3577 W 13 MILE RD
ROYAL OAK, MI 48073 - Phone
- (248) 551-7020
Quick Facts
- NPI
- 1467402172
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 26
- Publications
- 14
Are you this provider?
Claim Your Profile